Artyn - Company finances
|
EUR
|
2024
From: 2024-02-29
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 3,840 | 2,440 |
| Profit before tax | 1,924 | 1,213 |
| Net profit | 1,924 | 1,213 |
| Equity | 1,924 | 3,287 |
| Liabilities | 60 | 0 |
| Non-current assets | 0 | 0 |
| Current assets | 1,984 | 3,287 |
| Total assets | 1,984 | 3,287 |
|
Financial indicators
|
||
| Revenue change y/y | - | -36.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 97.0% | 36.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 36.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 50.1% | 49.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 50.1% | 49.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Artyn - Social security debts
The company had no debts to Sodra
Artyn - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Artyn, VšI (code 306693895) is a Public Institution operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €2.4K and net profit of €1.2K, with a profit margin of 49.7%. Revenue declined by 36.5% year on year from €3.8K in 2024, while net profit also decreased from €1.9K to €1.2K. Even with the lower turnover, the business remained profitable throughout the period.
The balance sheet also expanded in 2025: total assets and equity both reached €3.3K, indicating an equity ratio of 100.0% and no reported liabilities in the latest year. Asset turnover was 0.74x, showing that the company generated less than one euro of revenue per euro of assets during the year. Return on equity and return on assets were both 36.9%, reflecting profitability relative to the company’s small capital base. Overall, the 2024–2025 trajectory shows lower revenue but continued positive earnings and a stronger equity position.
The balance sheet also expanded in 2025: total assets and equity both reached €3.3K, indicating an equity ratio of 100.0% and no reported liabilities in the latest year. Asset turnover was 0.74x, showing that the company generated less than one euro of revenue per euro of assets during the year. Return on equity and return on assets were both 36.9%, reflecting profitability relative to the company’s small capital base. Overall, the 2024–2025 trajectory shows lower revenue but continued positive earnings and a stronger equity position.